Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system

Diabetes

Volumn 60, Issue 7, 2011, Pages 1882-1893

  Kovalik, Jean Paul ^a   Slentz, Dorothy ^a   Stevens, Robert D ^a   Kraus, William E ^a   Houmard, Joseph A ^b   Nicoll, James B ^c   Lea Currie, Y Renee ^c   Everingham, Karen ^d   Kien, C Lawrence ^d,e   Buehrer, Benjamin M ^c   Muoio, Deborah M ^a,f  

^a DUKE UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Zen Bio Inc   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; FATTY ACID; GLUCOSE; MESSENGER RNA; TRIACYLGLYCEROL; CARNITINE; DRUG DERIVATIVE; INSULIN;

ADIPOCYTE; ADIPOGENESIS; ADULT; AEROBIC METABOLISM; ARTICLE; CELL ACTIVATION; CELL METABOLISM; COCULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPOLYSIS; METABOLIC CAPACITY; MUSCLE CELL; MYOTUBE; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; BODY WEIGHT; DRUG EFFECT; METABOLISM; OBESITY;

ADIPOCYTES; CARNITINE; COCULTURE TECHNIQUES; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MUSCLE FIBERS, SKELETAL; OBESITY; THINNESS; TRIGLYCERIDES;

EID: 80052096458     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0427     Document Type: Article

References (51)

1. Haslam DW, James WPT. Obesity. Lancet 2005;366:1197-1209
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-1454 (Pubitemid 40396812)
3. Després J.-P. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38:52-63
4. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-1007
5. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18
6. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 2003;27(Suppl. 3):S6-S11 (Pubitemid 38019180)
7. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-229 (Pubitemid 34299024)
8. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003;14:137-145 (Pubitemid 36733912)
9. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-1081 (Pubitemid 41659117)
10. Dyck DJ, Heigenhauser GJF, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006;186:5-16
11. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946 (Pubitemid 32756432)
12. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000;11:212-217 (Pubitemid 30603166)
13. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002;51:2929-2935
14. Muoio DM, Way JM, Tanner CJ, et al. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 2002;51:901-909 (Pubitemid 34438329)
15. Consitt LA, Bell JA, Koves TR, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha overexpression increases lipid oxidation in myocytes from extremely obese individuals. Diabetes 2010;59:1407-1415. Epub 2010 Mar 3
16. Kim J-Y, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E1039-E1044
17. Kim J-Y, Koves TR, Yu G-S, et al. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 2002;282:E1014-E1022 (Pubitemid 34654714)
18. An J, Muoio DM, Shiota M, et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 2004;10:268-274
19. Kien CL, Everingham KI, D Stevens R, Fukagawa NK, Muoio DM. Shortterm effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity (Silver Spring) 2011;19: 305-311
20. Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005;36:207-224
21. Durheim MT, Slentz CA, Bateman LA, Mabe SK, Kraus WE. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. Am J Physiol Endocrinol Metab 2008;295:E407-E412
22. Kim CX, Bailey KR, Klee GG, et al. Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS ONE 2010;5:e9065
23. Van Hove JL, Zhang W, Kahler SG, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52:958-966 (Pubitemid 23313717)
24. Koves TR, Li P, An J, et al. Peroxisome proliferator-activated receptorgamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 2005;280:33588-33598 (Pubitemid 41397160)
25. Parikh H, Carlsson E, Chutkow WA, et al. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 2007;4:e158
26. Muoio DM, MacLean PS, Lang DB, et al. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR d. J Biol Chem 2002;277:26089-26097 (Pubitemid 34967092)
27. Kelley DE, Mintun MA, Watkins SC, et al. The effect of non-insulindependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 1996;97:2705-2713 (Pubitemid 26197085)
28. Cline GW, Magnusson I, Rothman DL, Petersen KF, Laurent D, Shulman GI. Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus. J Clin Invest 1997;99: 2219-2224 (Pubitemid 27203778)
29. 12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999;274: 24202-24210
30. Chavez JA, Knotts TA, Wang L-P, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003;278:10297-10303 (Pubitemid 36800291)
31. Chokkalingam K, Jewell K, Norton L, et al. High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: an important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab 2007;92:284-292 (Pubitemid 46067545)
32. Hoy AJ, Brandon AE, Turner N, et al. Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am J Physiol Endocrinol Metab 2009;297:E67-E75
33. Dietze D, Koenen M, Röhrig K, Horikoshi H, Hauner H, Eckel J. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 2002;51:2369-2376 (Pubitemid 34827384)
34. Dietze D, Ramrath S, Ritzeler O, Tennagels N, Hauner H, Eckel J. Inhibitor κB kinase is involved in the paracrine crosstalk between human fat and muscle cells. Int J Obes Relat Metab Disord 2004;28:985-992 (Pubitemid 38998703)
35. Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009;58:2731-2740
36. Famulla S, Lamers D, Hartwig S, et al. Pigment epithelium-derived factor is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes 2010 Oct 12 [Epub ahead of print]
37. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005;19:471-482 (Pubitemid 41819214)
38. Bays HE, González-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6:343-368
39. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789
40. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998;14:263-283 (Pubitemid 29110250)
41. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999;103:253-259 (Pubitemid 29053143)
42. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205 (Pubitemid 351301824)
43. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56
44. Anderson EJ, Lustig ME, Boyle KE, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573-581
45. Hoehn KL, Salmon AB, Hohnen-Behrens C, et al. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 2009;106:17787-17792
46. Hulver MW, Berggren JR, Carper MJ, et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2005;2:251-261
47. McAinch AJ, Steinberg GR, Mollica J, et al. Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity (Silver Spring) 2006; 14:1898-1904 (Pubitemid 46121919)
48. Bruce CR, Mertz VA, Heigenhauser GJF, Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 2005;54:3154-3160 (Pubitemid 43334369)
49. Shigetoh Y, Adachi H, Yamagishi S-i, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009;22:151-155
50. Huggett RJ, Burns J, Mackintosh AF, Mary DASG. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004;44:847-852 (Pubitemid 39577410)
51. Grassi G, Dell'Oro R, Quarti-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005;48: 1359-1365 (Pubitemid 41186102)